LLY vs MSFT
Eli Lilly and Company vs Microsoft Corporation
LLY
Eli Lilly and Company
$1082.76-2.01%
MSFT
Microsoft Corporation
$463.31+2.90%
Key Metrics Comparison
| LLY | Metric | MSFT |
|---|---|---|
| $1082.76 | Price | $463.31 |
| $1.02T | Market Cap | $3.44TBetter |
| 38.42 | P/E Ratio | 27.59Better |
| $28.18Better | EPS | $16.79 |
| -2.01% | Day Change | +2.90%Better |
| $1149.10 | 52W High | $555.45 |
| $623.78 | 52W Low | $356.28 |
| 1,758,816 | Volume | 40,896,461Better |
| 3,105,058 | Avg Volume | 36,687,892Better |
About Eli Lilly and Company
Healthcare | Drug Manufacturers - General
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a...
About Microsoft Corporation
Technology | Software - Infrastructure
Microsoft Corporation develops, licenses, and supports software, services, devices, and solutions worldwide. The company operates in three segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment offers Office, Exc...